Roche, Alnylam say blood pressure drug succeeds in mid-stage trial

Roche (ROG.S) and partner Alnylam (ALNY.O), opens new tab said on Tuesday their experimental drug against high blood pressure was shown to work when used in combination with the standard of care in a phase 2 trial.